Saudi Arabia Biopharmaceutical Third-Party Logistics Market Size & Outlook
The biopharmaceutical third-party logistics market in Saudi Arabia is expected to reach a projected revenue of US$ 3,548.5 million by 2033. A compound annual growth rate of 4.28% is expected of Saudi Arabia biopharmaceutical third-party logistics market from 2026 to 2033.
Saudi Arabia biopharmaceutical third-party logistics market highlights
The Saudi Arabia biopharmaceutical third-party logistics market generated a revenue of USD 2,530.3 million in 2025 and is expected to reach USD 3,548.5 million by 2033.
The Saudi Arabia market is expected to grow at a CAGR of 4.28% from 2026 to 2033.
In terms of segment, non-cold chain logistics was the largest revenue generating supplychain in 2025.
Cold Chain Logistics is the most lucrative supplychain segment registering the fastest growth during the forecast period.
Biopharmaceutical third-party logistics market data book summary
Market revenue in 2025
USD 2,530.3 million
Market revenue in 2033
USD 3,548.5 million
Growth rate
4.28% (CAGR from 2026 to 2033)
Largest segment
Non-cold chain logistics
Fastest growing segment
Cold Chain Logistics
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Non-cold Chain Logistics, Cold Chain Logistics
Key market players worldwide
DHL Group, SF Express, United Parcel Service Inc Class B, AmerisourceBergen Drug Corporation, DB Schenker, Kuehne + Nagel International AG, Kerry Logistics Network Ltd, Agility
Other key industry trends
In terms of revenue, Saudi Arabia accounted for 1.7% of the global biopharmaceutical third-party logistics market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Middle East & Africa, Saudi Arabia biopharmaceutical third-party logistics market is projected to lead the regional market in terms of revenue in 2033.
UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 2,207.7 million by 2033.
Saudi Arabia biopharmaceutical third party logistics market accounted for 22.5% market share in 2020 in the MEA market. According to the World Bank, the U.S. had a modest Logistics Performance Index (LPI) score of 3.01 in 2018.
The country has a modest transportation sector. The country’s initiative “vision 2030” is expected to improve investments for biopharmaceutical R&D and thus propelling the market growth of Saudi Arabia biopharmaceutical third party logistics market over the forecast period.
Saudi Arabia Biopharmaceutical Third-party Logistics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biopharmaceutical Third-party Logistics Market Outlook will help companies and investors design strategic landscapes.
Non-Cold Chain Logistics was the largest segment with a revenue share of 81.56% in 2025.
Horizon Databook has segmented the Saudi Arabia biopharmaceutical third-party logistics market based on non-cold chain logistics, cold chain logistics covering the revenue growth of each sub-segment from 2021 to 2033.
Saudi Arabia biopharmaceutical third party logistics market accounted for 22.5% market share in 2020 in the MEA market. According to the World Bank, the U.S. had a modest Logistics Performance Index (LPI) score of 3.01 in 2018.
The country has a modest transportation sector. The country’s initiative “vision 2030” is expected to improve investments for biopharmaceutical R&D and thus propelling the market growth of Saudi Arabia biopharmaceutical third party logistics market over the forecast period.
Saudi Arabia Biopharmaceutical Third-Party Logistics Market SupplyChain Outlook (Revenue, USD Million , 2021-2033)
Cold Chain Logistics
Non-cold Chain Logistics
Saudi Arabia Biopharmaceutical Third-Party Logistics Market Services Type Outlook (Revenue, USD Million , 2021-2033)
Transportation
Warehousing and Storage
Other Services
Reasons to subscribe to Biopharmaceutical Third-party Logistics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biopharmaceutical Third-party Logistics Market Outlook databook
Our clientele includes a mix of Biopharmaceutical Third-party Logistics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia Biopharmaceutical Third-party Logistics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia Biopharmaceutical Third-party Logistics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Saudi Arabia Biopharmaceutical Third-Party Logistics Market, 2021-2033 (US$M)